SCHEMBL7306444

SCHEMBL7306444

CCC(C(C)C(=O)NO)S(=O)(=O)c1ccc(OC)cc1

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 13/20 0.65
MMP2 P08253 11/20 0.65
MMP3 P08254 10/20 0.65
PDE4A P27815 4/20 0.65
PDE4B Q07343 4/20 0.65
PDE4C Q08493 4/20 0.65
PDE4D Q08499 4/20 0.65
MMP13 P45452 9/20 0.63
MMP9 P14780 8/20 0.63
ADAM17 P78536 4/20 0.60
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
CA9 Q16790 1/20 0.53
MMP8 P22894 2/20 0.49
MMP12 P39900 2/20 0.49
MMP14 P50281 1/20 0.49
MMP16 P51512 1/20 0.49
MMP7 P09237 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7301899 0.85 MMP1 (0.49) MMP1MMP2MMP3PDE4APDE4B
SCHEMBL6934594 0.80 MMP1 (0.73) MMP1MMP2MMP3PDE4APDE4B
SCHEMBL9246091 0.79 MMP1 (1.00) MMP1MMP2MMP3PDE4APDE4B
SCHEMBL13350334 0.79 MMP1 (1.00) MMP1MMP2MMP3PDE4APDE4B
SCHEMBL6823055 0.79 MMP1 (1.00) MMP1MMP2MMP3PDE4APDE4B
SCHEMBL8714771 0.77 MMP13 (0.73) MMP1MMP2MMP3PDE4APDE4B
SCHEMBL6929323 0.77 MMP13 (1.00) MMP1MMP2MMP3PDE4APDE4B
SCHEMBL6928607 0.77 MMP1 (1.00) MMP1MMP2MMP3PDE4APDE4B
SCHEMBL6927179 0.75 MMP1 (1.00) MMP1MMP2MMP3PDE4APDE4B
SCHEMBL1847769 0.75 MMP1 (1.00) MMP1MMP2MMP3PDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed